Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
PDE4DIP
REST API REST API
Homo sapiens
PDE4DIP is differentially expressed in 414 experiments: 218 organism parts: brain, heart, ... (216 more);, 330 disease states: normal, glioblastoma, ... (328 more);, 159 cell types 521 cell lines 60 compound treatments and 92 other conditions.
Synonyms MMGL, KIAA0454, CMYA2, KIAA0477
Orthologs ENSCING00000011994 (Ciona intestinalis)   A5PJD2_BOVIN (Bos taurus)   Pde4dip (Rattus norvegicus)   PDE4DIP (Danio rerio)   Pde4dip (Mus musculus)   cnn (Drosophila melanogaster)   ENSGALG00000011777 (Gallus gallus)   ENSGALG00000001650 (Gallus gallus)   pde4dip (Xenopus laevis)   PDE4DIP (Canis familiaris)   (Compare orthologs)
Gene Ontology Term protein binding, cytoskeleton, cytoplasm, Golgi apparatus, myofibril, centrosome, nucleus, enzyme binding, cellular protein complex assembly
InterPro Term Spindle_assoc
UniProt Accession Q5TB27, Q5VU43, E9PNE0, E9PQH9, E9PQG4, E9PQ86, E9PPE8, E9PS60, E9PRJ6, E9PI71, E9PIN2, E9PJ85, E9PJ64, E9PJA9, E9PJK3, E9PJU0, E9PL24, F8WAP5, F8WAP3
Search EB-eye ENSG00000178104
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-GEOD-22541, E-GEOD-6573, E-GEOD-1577, ... (37 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, E-GEOD-18005, E-GEOD-2450, ... (53 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-19639, E-GEOD-20081, E-GEOD-3529, E-GEOD-5823
SW480
4
E-MEXP-1014, E-GEOD-2509, E-MTAB-37, E-GEOD-18005
HL-60
3
E-GEOD-5258, E-MTAB-37, E-GEOD-24147
K562
3
E-MTAB-37, E-GEOD-24147, E-GEOD-96
H441
2
E-GEOD-16194, E-MTAB-62
SNU5
2
E-GEOD-15460, E-MTAB-37
515 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-MEXP-120, E-MEXP-750, E-GEOD-20677, ... (70 experiments)

Factor Value U/D Experiments
CD8+ T cell
3
E-GEOD-6740, E-MTAB-25, E-AFMX-5
stromal cell
1
3
E-GEOD-1460, E-MEXP-2034, E-GEOD-3998, E-GEOD-10797
mononuclear cell
2
E-GEOD-6053, E-GEOD-7307
partially reprogrammed human induced pluripotent stem cell
2
E-GEOD-18265, E-GEOD-18147
2
2
E-TABM-130, E-TABM-145
whole blood
2
E-GEOD-3026, E-MTAB-25
153 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-MEXP-1121, E-GEOD-1577, ... (84 experiments)

Factor Value U/D Experiments
control
1
4
E-GEOD-21912, E-GEOD-16363, E-GEOD-8121, E-GEOD-20295, E-GEOD-20168 ... (5 experiments)
acute promyelocytic leukemia
3
E-MTAB-62, E-GEOD-995, E-GEOD-96
astrocytoma
3
E-GEOD-4290, E-MTAB-37, E-MTAB-62
lung adenocarcinoma
3
E-MTAB-62, E-MTAB-37, E-MEXP-231
prostate carcinoma
3
E-MTAB-62, E-MEXP-2034, E-GEOD-7307
glioblastoma
2
4
E-MTAB-37, E-GEOD-6014, E-GEOD-4290, E-GEOD-4412, E-MEXP-567, ... (6 experiments)
324 more value(s).


Compound treatment

studied in E-GEOD-7400, E-GEOD-5258, E-GEOD-5741, E-TABM-782, E-GEOD-3720, ... (38 experiments)

Factor Value U/D Experiments
none
3
15
E-TABM-782, E-TABM-868, E-MEXP-1958, E-GEOD-5824, E-GEOD-412, ... (18 experiments)
lipopolysaccharide
3
E-TABM-868, E-MEXP-1958, E-GEOD-3720
glutamine
2
E-MEXP-1335, E-MEXP-941
ponasterone A
1
E-GEOD-3113
rapamycin
1
E-GEOD-5824
FCCP
1
E-MEXP-2285
54 more value(s).


Age at diagnosis

studied in E-GEOD-3494, E-GEOD-4922

Factor Value U/D Experiments
60
2
1
E-GEOD-3494
83 years
1
1
E-GEOD-4922
81 years
1
1
E-GEOD-4922


Agent
studied in E-GEOD-19519

Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-TABM-325, E-MTAB-37, E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd1a
studied in E-GEOD-22601

cd38
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-22097, E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, ... (9 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-1140, E-MEXP-1251, ... (10 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-5999, E-GEOD-3140, E-GEOD-20033, E-MEXP-958, ... (13 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease stage
studied in E-GEOD-7463

Disease staging
studied in E-GEOD-19743, E-GEOD-7788, E-GEOD-3325, E-GEOD-22541, E-GEOD-2509, ... (7 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-1643, E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Family relationship
studied in E-MEXP-1425

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, ... (9 experiments)

Genotype
studied in E-GEOD-1045, E-TABM-1029, E-GEOD-2466, E-GEOD-17476, E-GEOD-22593, ... (19 experiments)

Gestation age
studied in E-GEOD-14334

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-GEOD-5681, E-GEOD-7011, E-MEXP-2657, E-GEOD-20540, E-GEOD-22278, ... (20 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-GEOD-21653, E-TABM-276, E-GEOD-20194, E-GEOD-16716 ... (5 experiments)

Individual
studied in E-TABM-325, E-TABM-740, E-MEXP-2069, E-GEOD-1926, E-GEOD-4315, ... (44 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108, E-MEXP-561, E-GEOD-980, ... (7 experiments)

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214, E-GEOD-12662

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Localisation of metastases
studied in E-GEOD-22541

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-GEOD-9171

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-GEOD-426, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

Performer
studied in E-GEOD-2004, E-LGCL-5

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-7819, E-GEOD-1309, E-GEOD-1493, E-GEOD-22309, E-GEOD-21750, ... (10 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Protocol type
studied in E-GEOD-22097, E-GEOD-3254, E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, ... (6 experiments)

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-10797, E-GEOD-18791, E-GEOD-10896

Rna integrity
studied in E-TABM-325

RNAi
studied in E-GEOD-12438, E-MEXP-1509, E-MEXP-101, E-GEOD-3697, E-MEXP-1857, ... (6 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

Sample type
studied in E-TABM-783

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-16797, E-GEOD-19743, E-GEOD-21374, E-GEOD-17400, E-GEOD-18995 ... (5 experiments)

Sex
studied in E-GEOD-1643, E-GEOD-19743, E-GEOD-19069, E-GEOD-2466, E-GEOD-22541, ... (8 experiments)

Sirna
studied in E-GEOD-21575

Stimulation
studied in E-GEOD-13909, E-GEOD-4883, E-GEOD-20114, E-GEOD-11886, E-GEOD-11428 ... (5 experiments)

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996, E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Tissue
studied in E-GEOD-30573

tissue (organ)
studied in E-GEOD-22601

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-33562, E-GEOD-16837, E-MEXP-973, E-GEOD-21909, E-GEOD-19246, ... (8 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-GEOD-22541, E-GEOD-1561, E-GEOD-4922 ... (5 experiments)

Tumor size
studied in E-GEOD-3494, E-GEOD-6532

Vehicle
studied in E-GEOD-5258

Processing time: 0.353 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM